Evidence map›Paper›PMID 37134011›Full record

ArticleJBRA assisted reproduction2023

A sharing oocyte donation program: a 15-year cohort stud.

Talita Colombo, Marta Ribeiro Hentschke, Mariangela Badalotti, Ariane Tieko Frare Kira, Isadora Badalotti Telöken, Vanessa Devens Trindade, Victoria Campos Dornelles, Alvaro Petracco, Eliana Márcia Wendland

Open access · bronzeAbstract read
In one paragraph

Article in JBRA assisted reproduction, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Talita ColomboFederal University of Health Sciences of Porto Alegre (UFCSPA), Porto Alegre, Brazil.
Marta Ribeiro HentschkeFertilitat Reproductive Medicine Center, Porto Alegre, Brazil.
Mariangela BadalottiFertilitat Reproductive Medicine Center, Porto Alegre, Brazil.
Ariane Tieko Frare KiraFertilitat Reproductive Medicine Center, Porto Alegre, Brazil.
Isadora Badalotti TelökenFertilitat Reproductive Medicine Center, Porto Alegre, Brazil.
Vanessa Devens TrindadeFertilitat Reproductive Medicine Center, Porto Alegre, Brazil.
Victoria Campos DornellesFertilitat Reproductive Medicine Center, Porto Alegre, Brazil.
Alvaro PetraccoFertilitat Reproductive Medicine Center, Porto Alegre, Brazil.
Eliana Márcia WendlandFederal University of Health Sciences of Porto Alegre (UFCSPA), Porto Alegre, Brazil.
Fertility Medical Group · BRUniversidade Federal de Ciências da Saúde de Porto Alegre · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo evaluate clinical and laboratory outcomes of oocyte donation cycles and compare the results from donors and recipients.

methodsA retrospective cohort study was conducted at a reproductive medicine center. A 586 first fresh oocyte donation cycles, performed from 01/2002 to 12/2017 were included. The outcomes of 290 cycles from donors and 296 from recipients, resulting in 473 fresh embryo transfers, were analyzed. The oocyte division was equally made, whereas, at an odd amount, the donor always had a preference. The data were collected from an electronic database, and analyzed using Chi-square test, Fisher's exact test, Mann-Whitney U-test or Student t-test depending on the data distribution, and multivariate logistic regression, considering p<0.05.

resultsThe main results comparing donor and recipient, were, respectively: fertilization rate (72.0±21.4 vs. 74.6±24.2, p<0.001), implantation rate (46.2% vs. 48.5%, p=0.67); clinical pregnancy rate (41.9% vs. 37.7%, p=0.39), live birth rates by transfer (33.3 vs. 37.7, p=0.54).

conclusionsOocyte donation is often the way donors can access in vitro fertilization, and for recipients seems to be a good option for pregnancy. Demographic and clinical characteristics have a secondary role in oocyte donors under 35 years and patient without comorbidities under 50 years and were not associated with pregnancy outcomes, emphasizing the power of oocyte quality on the success of intracytoplasmic sperm injection treatment. An oocyte-sharing program that offers good and comparable results is fair and worth being encouraged.

Indexed as

Oocyte DonationSemenFemaleFertilization in VitroHumansMaleOocytesPregnancyPregnancy OutcomePregnancy RateRetrospective StudiesIVFoocyte donationreproductive outcomes

Identifiers

PMID37134011
PMCPMC10712811
OpenAlexW4321637342

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.